Surgery Following Induction (Neoadjuvant) Therapy with Pembrolizumab in Lung Adenocarcinoma with High PD-L1 Expression. Respirar, [S. l.], v. 17, n. 1, p. 68–75, 2025. DOI: 10.55720/respirar.17.1.6. Disponível em: https://respirar.alatorax.org/index.php/respirar/article/view/268. Acesso em: 25 aug. 2026.